Abstract
The intraperitoneal delivery of chemotherapeutic agents is presently being investigated as a part of salvage treatment for epithelial ovarian cancer. These are several promising new agents that appear to demonstrate a benefit in selected patients.
Original language | English (US) |
---|---|
Pages (from-to) | 23-27 |
Number of pages | 5 |
Journal | Current Opinion in Obstetrics and Gynecology |
Volume | 11 |
Issue number | 1 |
DOIs | |
State | Published - Feb 1 1999 |
Externally published | Yes |
ASJC Scopus subject areas
- Obstetrics and Gynecology